Close Menu
    What's Hot

    Editor’s Letter – Volume 4, Issue 6, June 2025

    12 June 2025

    Both Demand and Supply Factors Contribute to Rare Secondary Market Pullback in 2024

    12 June 2025

    Funded Reinsurance Under Scrutiny But Should Remain a Feature of the UK Pension risk Transfer Market

    12 June 2025
    Facebook X (Twitter) Instagram
    Instagram LinkedIn X (Twitter)
    Life Risk News
    • Home
    • Features

      Both Demand and Supply Factors Contribute to Rare Secondary Market Pullback in 2024

      12 June 2025

      Funded Reinsurance Under Scrutiny But Should Remain a Feature of the UK Pension risk Transfer Market

      12 June 2025

      Plenty of Guardrails for US Life Insurers Backing Group Annuities With Private Assets

      12 June 2025

      Liver Disease Mortality in England Continues to Worsen but General Mortality Still on a Post-Covid Downward Trend

      12 June 2025

      Q&A: Matthew Sheridan, Health Data Analytics

      12 June 2025
    • Commentary

      Life Expectancy in Breast Cancer

      12 June 2025

      The Healthy Wealthy Population of the Life Settlement Market

      12 June 2025

      UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

      14 May 2025

      The Power of Uncorrelated Diversification During Market Volatility

      14 May 2025

      Overseeing BPA Growth Safely

      14 May 2025
    • Events
    • Magazine
    • News

      The London Waste Limited Pension Scheme Completes Bulk Purchase Annuity Buy-In with Royal London

      2 June 2025

      Morrisons Retirement Saver Plan Completes Bulk Purchase Annuity Buy-In With Aviva

      28 May 2025

      Yellow Pages Limited Purchases Group Annuity Contracts From BMO Life Assurance Company

      22 May 2025

      Andrew Limited Pension and Life Assurance Plan Completes Bulk Annuity Transaction With Aviva

      15 May 2025

      Life Insurance Settlement Association Publishes Latest Market Data Collection Survey Results

      13 May 2025
    Subscribe
    Life Risk News
    Home » US Pension Risk Transfer Market To Continue Bull Run in 2025 – and Beyond

    US Pension Risk Transfer Market To Continue Bull Run in 2025 – and Beyond

    Features 15 January 2025Greg WintertonBy Greg Winterton
    Twitter LinkedIn Email
    Share
    Twitter LinkedIn Email

    When all is said and done, 2024 could end up delivering aggregate premium at or close to the US pension risk transfer (PRT) market’s current banner year of 2022, where $51.9bn worth of deals was written in the space. 

    That is according to the November 2024 edition of Legal and General Retirement America (LGRA)’s Pension– Risk Transfer Monitor, a quarterly report the firm publishes that tracks activity in the market. A total of $14bn of deals were completed in the third quarter of this year alone, with IBM’s $6bn deal with Prudential a notable transaction. 

    On both sides of the Atlantic, the media coverage of the space tends to relate to the aggregate size of the market in dollars or sterling, but it isn’t a case of a handful mega deals exaggerating the size of the market; indeed, there is plenty of activity across all scheme sizes to keep pension scheme and insurance actuaries busy. 

    “In 2023, around 800 PRT contracts were signed,” said George Palms, President at LGRA.  

    “And this year, there has also been an upward trend in PRT transactions between $500 and $999m. From what we have seen, the total amount of premium in the $500m-$1bn space is around $9bn in total, compared to $6bn in 2023. There has been plenty of growth in the middle-to-large market in the US this year.” 

    When interest rates began to rise two years or so ago, there was talk in the UK that some smaller schemes might get crowded out of the market due to the bigger deals taking precedence. In terms of human capital, the ratio of effort expended to deal size to complete a smaller transaction is higher than it is for a larger deal, but that concern has not materialised. 

    The smaller end of the market is similarly healthy stateside, albeit, for different reasons. 

    “It is important to point out that in the US, there are around 20 insurers in the market, and they all have different appetites for deals in different segments. You may see a deal where the total value is below $100m and you will have over eight bidders on that transaction. That’s not uncommon,” said Palms. 

    Success in the PRT market relies heavily on accurate mortality modelling, and the US market has seen positive developments in this area that are supporting the recent growth. 

    “We’ve noticed a growing sophistication in mortality modeling in the US PRT market, with the majority of insurers now using multi-factor models in their baseline assumptions to capture the predictive power of factors such as ZIP+4, collar type, benefit amount and gender. Insurers are now commonly using multiple factors simultaneously to capture differences in mortality rates at the individual member level, and those not using such models run the risk of adverse selection,” said Erik Pickett, Actuary and Chief Content Officer at Club Vita. 

    “We’ve also seen a growing focus on mortality improvement assumptions as insurers face the uncertainty of the long-term impact of the Covid-19 pandemic. This is the area of greatest divergence in mortality assumption setting, although there does seem to be an increasing consensus to reflect higher expected mortality improvements in the defined benefit pensioner population over the general population,” he added. 

    Additionally, Pickett observed that, similar to the UK market, there is a strong focus on data quality stateside. 

    “With a greater dependency on data to set mortality assumptions, the value of complete clean data from pension plans looking to transact is high. When this is unavailable it is common for insurers to add extra margin to deals to cover the uncertainty introduced,” he said. 

    A big news story this year in the US market was the Department of Labor’s report to Congress published in June reviewing the Employee Benefits Security Administration’s Interpretive Bulletin 95-1 (IB95-1).  

    IB95-1 was originally written in 1995, and essentially determines the type of transactions completed in the market – full scheme buy-outs, as opposed to the more common buy-in transactions seen in the UK market, due to the ‘safest annuity available’ clause in the regulation. 

    “Buy-ins are more difficult to complete in the US because of the safest available annuity clause in IB95-1. An insurer may be the safest available at inception, but then in two or three years, they may not be any longer,” said Palms. 

    “But there are maybe a dozen buy-ins a year, although they are used in specialised situations like a plan termination. They are used to lock in the cost of the transaction to the plan sponsor up front and then the move from buy-in to buy-out happens in less than a year when consummating the termination of the plan.” 

    Those plan sponsors that are looking to do a deal had better act fast. Americans are famous – infamous? – for working long hours, and Palms said that there could well be a deal completed between Christmas and New Year last year, when most Europeans would have been…not working. Additionally, in the US, their financial and tax year ends on December 31st, so there is plenty of activity during the festive period to close out the year-end as strongly as possible. 

    But the first quarter of the calendar year tends to be less busy, and benefits are on offer for those ready to begin the process earlier in the year. 

    “Historically in the US, one piece of advice I would have to a plan sponsor is if you have a transaction, bring it in Q1. Volume is typically lower in Q1, but insurers are eager to start writing business. It’s a good time to transact, with a lot of participation. Schemes can get a more favourable PRT premium than they can in the fourth quarter, when things are much busier. Insurers may become more selective which can lead to fewer bidders in the fourth quarter.” 

    Whether plan sponsors come to market in the first quarter of 2025, or the fourth quarter, will not make much of a difference to the macro picture, however, which is robust, to say the least – and should stay that way. 

    Consultants Milliman publish the Milliman 100 Pension Funding Index, which shows the firm’s view of the funded status of the 100 largest corporate defined benefit pension plans in the US. The November 2024 edition suggests that the funded ratio jumped to 103.4%, from 102.5% at the end of September, and the funded status surplus increased to $43bn.  

    While the Milliman Index has only been in surplus in recent years, schemes tend to lock in their funded status via hedging tools. Add to that the sheer size of the market in the US – the runway is long – very long – and the market should continue to hit new highs in the coming years. 

    “In the United States, there are more than $3trn in defined benefit pension liabilities and only about 10% of that has been de-risked so far. The steady march up in terms of taking liabilities off balance sheets will continue due to secular trends around de-risking and strong funding levels,” said Palms. 

    “In the next five years, I’d expect the market to eclipse the current high of $51.9bn and I wouldn’t be surprised if the new high-water mark will be $100bn. The market will step up to a new level.” 

    2025 - January Longevity and Mortality Risk Transfer Pension Risk Transfer Volume 4 Issue 1 - January 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Both Demand and Supply Factors Contribute to Rare Secondary Market Pullback in 2024

    12 June 2025

    Funded Reinsurance Under Scrutiny But Should Remain a Feature of the UK Pension risk Transfer Market

    12 June 2025

    Plenty of Guardrails for US Life Insurers Backing Group Annuities With Private Assets

    12 June 2025

    Liver Disease Mortality in England Continues to Worsen but General Mortality Still on a Post-Covid Downward Trend

    12 June 2025

    Comments are closed.

    Most Popular

    Both Demand and Supply Factors Contribute to Rare Secondary Market Pullback in 2024

    12 June 2025

    Funded Reinsurance Under Scrutiny But Should Remain a Feature of the UK Pension risk Transfer Market

    12 June 2025

    Plenty of Guardrails for US Life Insurers Backing Group Annuities With Private Assets

    12 June 2025

    Liver Disease Mortality in England Continues to Worsen but General Mortality Still on a Post-Covid Downward Trend

    12 June 2025
    Ad

    Your trusted source for capital markets participation in Life Risk

    X (Twitter) Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Terms and Conditions
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT